Guggenheim Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Guggenheim Capital’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.64M	Buy	64,517 +15,808	+32%	+$922K	0.03%	520
2025 Q4	$2.89M	Buy	48,709 +8,223	+20%	+$448K	0.02%	572
2025 Q3	$2.19M	Buy	40,486 +3,618	+10%	+$207K	0.02%	663
2025 Q2	$2.03M	Buy	36,868 +2,588	+8%	+$152K	0.02%	658
2025 Q1	$2.42M	Sell	34,280 -3,400	-9%	-$229K	0.02%	588
2024 Q4	$2.48M	Sell	37,680 -2,275	-6%	-$152K	0.02%	582
2024 Q3	$2.81M	Sell	39,955 -1,367	-3%	-$114K	0.02%	710
2024 Q2	$3.4M	Sell	41,322 -4,730	-10%	-$394K	0.02%	646
2024 Q1	$4.02M	Buy	46,052 +4,487	+11%	+$402K	0.03%	636
2023 Q4	$4.01M	Sell	41,565 -3,690	-8%	-$326K	0.03%	594
2023 Q3	$4M	Sell	45,255 -4,350	-9%	-$387K	0.03%	562
2023 Q2	$4.3M	Buy	49,605 +6,704	+16%	+$631K	0.03%	574
2023 Q1	$4.17M	Sell	42,901 -5,004	-10%	-$519K	0.04%	585
2022 Q4	$4.96M	Buy	47,905 +2,024	+4%	+$190K	0.04%	532
2022 Q3	$3.89M	Sell	45,881 -10,087	-18%	-$898K	0.04%	592
2022 Q2	$4.64M	Sell	55,968 -2,878	-5%	-$229K	0.04%	574
2022 Q1	$4.54M	Sell	58,846 -7,161	-11%	-$599K	0.03%	688
2021 Q4	$5.83M	Buy	66,007 +2,148	+3%	+$177K	0.03%	624
2021 Q3	$4.94M	Buy	63,859 +997	+2%	+$78.7K	0.03%	662
2021 Q2	$5.25M	Sell	62,862 -2,131	-3%	-$169K	0.03%	660
2021 Q1	$4.91M	Buy	64,993 +3,216	+5%	+$263K	0.03%	637
2020 Q4	$5.42M	Sell	61,777 -46,553	-43%	-$3.69M	0.03%	545
2020 Q3	$8.24M	Sell	108,330 -4,605	-4%	-$466K	0.06%	343
2020 Q2	$13.9M	Buy	112,935 +8,418	+8%	+$837K	0.11%	179
2020 Q1	$8.83M	Sell	104,517 -19,436	-16%	-$1.67M	0.09%	241
2019 Q4	$10.5M	Buy	123,953 +10,079	+9%	+$761K	0.08%	307
2019 Q3	$7.67M	Sell	113,874 -2,196	-2%	-$169K	0.06%	405
2019 Q2	$9.94M	Sell	116,070 -6,266	-5%	-$536K	0.08%	292
2019 Q1	$10.9M	Buy	122,336 +5,570	+5%	+$516K	0.09%	258
2018 Q4	$9.94M	Sell	116,766 -6,341	-5%	-$603K	0.09%	263
2018 Q3	$11.9M	Sell	123,107 -5,632	-4%	-$562K	0.08%	298
2018 Q2	$12.1M	Sell	128,739 -3,663	-3%	-$321K	0.09%	272
2018 Q1	$10.7M	Buy	132,402 +1,944	+1%	+$167K	0.03%	657
2017 Q4	$11.6M	Sell	130,458 -17,699	-12%	-$1.54M	0.03%	642
2017 Q3	$13.8M	Buy	148,157 +5,201	+4%	+$460K	0.04%	582
2017 Q2	$13M	Buy	142,956 +3,163	+2%	+$288K	0.03%	593
2017 Q1	$12.3M	Buy	139,793 +900	+0.6%	+$80.1K	0.03%	609
2016 Q4	$11.5M	Sell	138,893 -7,848	-5%	-$675K	0.03%	621
2016 Q3	$13.6M	Sell	146,741 -3,726	-2%	-$351K	0.04%	581
2016 Q2	$11.7M	Buy	150,467 +455	+0.3%	+$38.7K	0.04%	621
2016 Q1	$12.4M	Sell	150,012 -40,356	-21%	-$3.28M	0.04%	641
2015 Q4	$19.9M	Sell	190,368 -22,865	-11%	-$2.39M	0.06%	562
2015 Q3	$22.5M	Buy	213,233 +7,598	+4%	+$1.01M	0.07%	511
2015 Q2	$28.1M	Buy	205,635 +19,747	+11%	+$2.45M	0.07%	518
2015 Q1	$23.2M	Buy	185,888 +22,502	+14%	+$2.38M	0.06%	605
2014 Q4	$14.8M	Buy	163,386 +9,941	+6%	+$827K	0.04%	708
2014 Q3	$11.1M	Buy	153,445 +900	+0.6%	+$59.1K	0.03%	848
2014 Q2	$9.49M	Sell	152,545 -20,826	-12%	-$1.26M	0.02%	875
2014 Q1	$11.8M	Buy	173,371 +17,577	+11%	+$1.3M	0.03%	800
2013 Q4	$10.9M	Sell	155,794 -3,778	-2%	-$257K	0.03%	798
2013 Q3	$11.5M	Sell	159,572 -30,022	-16%	-$2M	0.04%	778
2013 Q2	$10.6M	Buy	+189,594	New	+$11.8M	0.04%	742